Citadel Advisors - CYTEIR THERAPEUTICS INC ownership

CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103. A total of 46 filers reported holding CYTEIR THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CYTEIR THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$34,723
-78.6%
21,044
-50.8%
0.00%
Q1 2022$162,000
-66.4%
42,746
+55.4%
0.00%
Q3 2021$482,00027,5100.00%
Other shareholders
CYTEIR THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
OUP Management Co., LLC 2,474,572$9,329,0007.10%
Novo Holdings A/S 4,840,413$18,248,0000.96%
RA Capital Management 3,350,506$12,631,0000.28%
Avidity Partners Management LP 1,850,000$6,975,0000.14%
ACT CAPITAL MANAGEMENT, LLC 15,000$57,0000.06%
Baker Brothers Advisors 812,640$3,064,0000.02%
CAAS CAPITAL MANAGEMENT LP 105,091$396,0000.02%
Evercore Wealth Management, LLC 146,676$553,0000.01%
Jump Financial, LLC 21,300$80,0000.00%
JANUS HENDERSON GROUP PLC 1,719,610$6,486,0000.00%
View complete list of CYTEIR THERAPEUTICS INC shareholders